![Anand Parikh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anand Parikh
Vorstandsvorsitzender bei
FAETH THERAPEUTICS, INC.
Vermögen: 20 Mio $ am 30.06.2026
Profil
Anand Parikh is the founder of Faeth Therapeutics LLC, founded in 2019, holding the titles of President, Chief Executive Officer & Director since 2026.
Mr. Parikh currently holds the position of Chairman, President & Chief Executive Officer at Faeth Therapeutics, Inc. since 2026.
Mr. Parikh completed undergraduate education at the University of Michigan and graduate education at New York University School of Law.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.06.2026 | 817’699 ( 3.17% ) | 20 Mio $ | 30.06.2026 |
Aktive Positionen von Anand Parikh
| Unternehmen | Position | Beginn |
|---|---|---|
| FAETH THERAPEUTICS, INC. | Vorstandsvorsitzender | 13.06.2026 |
Faeth Therapeutics, Inc.
 Faeth Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision nutrition cancer treatment solutions which uses metabolism to starve cancer cells | Gründer | 01.04.2019 |
Ausbildung von Anand Parikh
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
9
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University School of Law
 New York University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Faeth Therapeutics, Inc.
Faeth Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision nutrition cancer treatment solutions which uses metabolism to starve cancer cells | Health Technology |
Sensei Biotherapeutics, Inc.
 Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
